Page last updated: 2024-09-04

rhodioloside and Hyperoxia

rhodioloside has been researched along with Hyperoxia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Di, X; Gong, G; Guo, B; Hou, Y; Hu, Z; Huang, Y; Liang, Z; Liu, X; Wang, L; Xu, B; Zhang, X; Zuo, Z	1

Other Studies

1 other study(ies) available for rhodioloside and Hyperoxia

Article	Year
Salidroside attenuates HALI via IL-17A-mediated ferroptosis of alveolar epithelial cells by regulating Act1-TRAF6-p38 MAPK pathway. Cell communication and signaling : CCS, 2022, 11-21, Volume: 20, Issue:1 Topics: Acute Lung Injury; Alveolar Epithelial Cells; Animals; Carrier Proteins; Cytokines; Ferroptosis; Hyperoxia; Interleukin-17; Interleukin-6; Mice; p38 Mitogen-Activated Protein Kinases; TNF Receptor-Associated Factor 6; Transforming Growth Factor beta1	2022

Article

Year

Salidroside attenuates HALI via IL-17A-mediated ferroptosis of alveolar epithelial cells by regulating Act1-TRAF6-p38 MAPK pathway.

Cell communication and signaling : CCS, 2022, 11-21, Volume: 20, Issue:1

Topics: Acute Lung Injury; Alveolar Epithelial Cells; Animals; Carrier Proteins; Cytokines; Ferroptosis; Hyperoxia; Interleukin-17; Interleukin-6; Mice; p38 Mitogen-Activated Protein Kinases; TNF Receptor-Associated Factor 6; Transforming Growth Factor beta1

2022